Research Indicates How Prevention Research Helps Stall New HIV Infections
An expert has revealed how prevention research and use of Pre-Exposure Prophylaxis (PrEP), will help improve the health of the populace through achieving reduced new HIV infections.
Dr James Anenih, the head of Research at the National Agency for Control of AIDS (NACA), spoke on the status of PrEP which are drugs that people take to prevent them from getting HIV infection.
According to Anenih, about two years ago the PrEP demonstration study was launched in Nigeria, he explained that PrEP is a procedure for people who do not have HIV but who are at substantial risk of contracting the virus; to prevent HIV infection they take a pill daily.